Serum S100B levels were increased only in the subgroup of neonates with severe encephalopathy, while NSE levels were significantly correlated with the grading of encephalopathy, providing excellent prognostic ability, as shown in detail earlier [97]. This evidence concerns the gene S100B and Encephalopathy.